Best Life Sciences Companies in Concord, United States
The 34 best Life Sciences companies in Concord, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Cerus.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Concord
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Cerus Provider of pathogen inactivation technology for blood center or hospital blood bank | $159M | 80 mo ago | Public | 247 247 → 386 (+56%) | — | WordPressMySQLPHP+24 | 326 patents Pathogen inactivation and processing technologies for blood products and cellular therapies | — |
| 2 | Comanche Developer of RNA therapeutics to treat preeclampsia | $111M | 33 mo ago | Series B | 17 | Mike Young Co-Founder & President | WordPressMySQLPHP+23 | — | — |
| 3 | Biocare Medical Manufacturer of primary antibodies and instruments for immunohistochemistry applications | $85M | 58 mo ago | Acquired | 137 137 → 295 (+115%) | — | Cart FunctionalityWooCommerceWordPress+37 | — | — |
| 4 | Valerion Therapeutics Premium home theater projectors delivering world-class image quality and cinematic experiences | $30M | 136 mo ago | Series B | 1 | Timothy Harris Co-Founder | ShopifyCart FunctionalityTurbopack+31 | — | — |
| 5 | Cristcot Pharmaceutical company developing a novel rescue drug for ulcerative colitis flares | $27M | 18 mo ago | Series C | 4 | — | Squarespace CommerceSquarespaceApple iCloud Mail+14 | 73 patents Rectal drug delivery formulations and single-use insertion devices for gastrointestinal therapies | — |
| 6 | Corista Software solutions for optimizing digital pathology workflow | $13M | 43 mo ago | Series B | 26 26 → 34 (+31%) | — | — | 54 patents Digital pathology: whole-slide imaging, multi-resolution registration, and AI-driven analysis | — |
| 7 | Game Ready Injury and surgery recovery systems using cold, heat, and compression therapy | $9M | 185 mo ago | Acquired | 117 117 → 156 (+33%) | — | WordPressMySQLPHP+22 | — | — |
| 8 | MyPurMist Natural steam inhalers and air purifiers for respiratory relief | $9M | 126 mo ago | Seed | 5 | Lars Barfod Chief Executive Officer | Cart FunctionalityShopifySentry+43 | — | — |
| 9 | Prapela Innovating newborn care with FDA-authorized stimulation therapy for infant health | $8M | 19 mo ago | Funding Raised | 4 | Jim Niemi Co-Founder | WixSentryBootstrap+11 | — | — |
| 10 | Bolt Provider of a spine surgical navigation solution for healthcare professionals | $6M | 33 mo ago | Series B | 7 | — | — | 39 patents Patents concentrated in health & consumer products | — |
| 11 | Owater Functional beverage company manufacturing of sports drink products for athletes | $6M | 217 mo ago | Deadpooled | 11 | — | — | — | — |
| 12 | Artugen Therapeutics Developer of microbiome therapeutics to treat infectious and inflammatory diseases | $5M | 56 mo ago | Series A | 10 | — | — | — | — |
| 13 | Kantum Pharma Developer of therapies for treating acute kidney injury | $4M | 63 mo ago | Series A | — | Sylvie Breton Founder | — | — | — |
| 14 | Future Path Device for hospital urinary management | $3M | 142 mo ago | Deadpooled | — | Ty Bryant Owner | — | — | — |
| 15 | Fairbanks Pharmaceuticals Togel: Hongkong lottery results, data, and live draw services | $2M | 126 mo ago | Funding Raised | — | Alan Schneyer Co-Founder & CEO | — | — | — |
| 16 | Castlewood Surgical Proximal anastomosis system for cardiovascular procedures | $1M | 172 mo ago | Deadpooled | — | — | — | — | — |
| 17 | Lennham Developer of deuterium chemistry-based therapeutics for multiple diseases | $1M | 42 mo ago | Funding Raised | 2 | Brad Sippy Founder | — | — | — |
| 18 | ONEighty C Technologies Developer of medical device sterilization and verification system | $360K | 161 mo ago | Seed | — | David Smith Chairman & Co-CEO | — | — | — |
Top 12 Life Sciences companies in Concord
#1
Series C · Concord, Massachusetts · founded 2008 · 4 employees$26.9Mraised▾
Pharmaceutical company developing a novel rescue drug for ulcerative colitis flares. Focused on gastroenterology, the company addresses unmet needs in disease management with a low competitive landscape. Their lead product, completing Phase 3 trials, aims for clinical remission with mucosal healing in just four weeks, offering a unique rescue option for ulcerative colitis patients, alone or with maintenance therapies. The company's patented suppository, utilizing a novel hydrocortisone acetate formulation and applicator, ensures consistent drug delivery and eliminates leakage. With a strong IP portfolio extending market exclusivity, they are poised to provide relief from debilitating rectal symptoms and improve the quality of life for those living with ulcerative colitis. This innovative approach solves an unmet need in ulcerative colitis treatment.
- Apr 2025Series C$10.5M
- Apr 2024Series B$7M
- Oct 2019Series B$13.7M
- Aug 2017Series A$411.4K
#2
Funding Raised · Concord, Massachusetts · founded 2017 · 4 employees$8Mraised▾
Innovating newborn care with FDA-authorized stimulation therapy for infant health. They are transforming newborn care through innovative stimulation therapy, improving infant health outcomes. They focus on developing and commercializing medical devices for newborns, particularly those affected by Neonatal Opioid Withdrawal Syndrome (NOWS) and Apnea of Prematurity. Their core technology involves stochastic vibrotactile stimulation (SVS), a gentle stimulation method that supports healthy breathing, heart rate, and oxygenation in newborns. They offer hospital bassinet pads and are developing incubator pads. They partner with hospitals and neonatal equipment manufacturers to integrate their technology into existing products. Their work has a significant social impact, addressing the opioid crisis's effects on newborns and improving the quality of care for premature infants. They are involved in clinical trials and research to further advance their stimulation therapy.
- Mar 2025Grant (prize money)$3.5M
- Jun 2021Grant (prize money)—
- Sep 2019Grant (prize money)$200K
- Aug 2019Grant (prize money)$1M
#3
Series B · Concord, Massachusetts · founded 2020 · 17 employees$111.1Mraised▾
Developer of RNA therapeutics to treat preeclampsia. The company is developing siRNA compounds that are capable of silencing the sFLT-1 gene in the placenta to halt the production of the protein responsible for preeclampsia.
- Jan 2024Series B$75M
- Jun 2021Series A$36.1M
#4
Public · Concord, California · founded 1991 · 247 employees$159Mraised▾
Provider of pathogen inactivation technology for blood center or hospital blood bank. The company's product "INTERCEPT system" allows high throughput processing of platelets and plasma from whole blood and apheresis collections. The device uses amotosalen-based pathogen inactivation technology to ensure reduced risk of transfusion-transmitted diseases by inactivating a variety of pathogens such as viruses, bacteria, and parasites.
- Feb 2020Grant (prize money)—
- Apr 2019Conventional Debt$75M
- Aug 2011Grant (prize money)$2.1M
- Sep 2010Grant (prize money)$1.4M
#5
Series B · Concord, Massachusetts · founded 2018 · 7 employees$6.4Mraised▾
Provider of a spine surgical navigation solution for healthcare professionals
- Jan 2024Series B$5.8M
- Dec 2021Series A—
- Jun 2020Seed$590K
#6
Acquired · Concord, California · founded 1997 · 137 employees$85Mraised▾
Manufacturer of primary antibodies and instruments for immunohistochemistry applications. It offers a wide range of antibodies targeting various proteins, including CD antigens, cytokeratins, and others. These antibodies are used in various research and diagnostic settings to detect specific proteins and markers. It aids in disease diagnosis and research, particularly in the fields of oncology, immunology, and pathology.
- Dec 2021PE—
- Aug 2017PE$85M
#7
Series B · Concord, Massachusetts · founded 2005 · 26 employees$13.2Mraised▾
Software solutions for optimizing digital pathology workflow. The company offers to integrate WSI image scanning systems, image analytics, and LIS/EHR platforms with a rich collaborative environment for physicians, patients, bio-tech, and pharmaceutical scientists.
- Mar 2023Series B$13.2M
#8
Series B · Concord, Massachusetts · founded 2002 · 1 employees$30Mraised▾
Premium home theater projectors delivering world-class image quality and cinematic experiences. This company specializes in high-end home entertainment solutions, focusing on projectors designed for ultimate black levels and exceptional visuals. They offer cutting-edge technology to redefine global home entertainment. Their products are studio-calibrated and director-approved, ensuring top-tier cinematic visuals with smart features. They provide fast and free shipping, a warranty, a money-back guarantee, and customer service. The company aims to provide a versatile and powerful laser projector experience, suitable for both movies and gaming, with features like high brightness, contrast, and accurate color reproduction. They offer a range of projectors with features like optical zoom and Dolby Vision, providing flexibility in screen size. Their projectors are known for their sharpness and performance, making them a top choice for home theater enthusiasts. They also offer accessories and bundles to enhance the viewing experience.
- 2015Series B$10M
- Mar 2012Series A$20M
- Aug 2009Grant (prize money)$336.7K
- Jul 2009Grant (prize money)$336.7K
#9
Series A · Concord, Massachusetts · founded 2018 · 10 employees$5Mraised▾
Developer of microbiome therapeutics to treat infectious and inflammatory diseases. It has developed novel live biotherapeutic products to treat patients with infectious diseases like Clostridium difficile infection, inflammatory of gut-organ, and oncologic diseases. The team has discovered and is developing a novel oral live biotherapeutic product for the prevention of C. difficile infection recurrence.
- Feb 2022Series A$5M
#10
Funding Raised · Concord, Massachusetts · founded 2019 · 2 employees$1.2Mraised▾
Developer of deuterium chemistry-based therapeutics for multiple diseases. The company's candidates include D-caffeine for narcolepsy, ADHD, D-Psilocybin for PTSD, and D-Androgen receptor agonist for breast cancer, and female sexual dysfunction.
- Apr 2023Conventional Debt$1.2M
#11
Seed · Concord, California · founded 2001 · 5 employees$8.9Mraised▾
Natural steam inhalers and air purifiers for respiratory relief. The company offers steam inhalers and air purifiers designed to provide natural, drug-free relief from allergies, sinus congestion, colds, and flu. Their products utilize pure warm humidity to soothe sinuses, mouth, and throat. They are presented as effective alternatives to nasal irrigation methods. The company emphasizes the purity of its steam, claiming it to be germ-free and allergen-free. The inhalers are portrayed as cordless, handheld, and portable, suitable for the whole family. They are recommended by doctors for various respiratory ailments, including allergies, sinusitis, laryngitis, and sore throats. The company also promotes a skin rejuvenation device using light therapy for minimizing lines, wrinkles, and spots. The website offers options for login, cart, checkout, product registration, and support.
- Apr 2016Seed$982.3K
- Dec 2013Seed$1.1M
- Nov 2012Seed$2.5M
- Nov 2010Seed$1.1M
#12
Acquired · Concord, California · founded 1997 · 117 employees$9Mraised▾
Injury and surgery recovery systems using cold, heat, and compression therapy. They provide advanced therapeutic units and wraps for injury and post-operative recovery. Their systems are used by orthopedic specialists, physical therapists, athletic trainers, and professional sports teams. They offer portable cold and compression recovery systems, multi-modality recovery systems integrating cold, heat, compression, and contrast therapies. They also provide a full-service rental program with electronic paperwork, insurance billing, product usage education, and contactless delivery and returns, supported by nurse assistance. Their patented dual-action wraps offer enhanced anatomical coverage. They focus on helping patients and athletes recover strong and get back to what matters through innovative recovery solutions. They also partner with sports teams to support peak athletic performance.
- May 2011Series B$4M
- Jun 2010Conventional Debt$2.2M
- Aug 2009Series A$2M
- Aug 2007Series A$3M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in the United States
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 6,260 United States-affiliated papers.
- Harvard University209
- Cornell University177
- University of Tennessee at Chattanooga140
- Howard Hughes Medical Institute126
- Johns Hopkins University121
- Gene33→164
- Transcription (linguistics)11→79
- Antibody11→62
- Genome6→56
- Mutation7→56
- Gene8→110
- Cell culture3→62
- Gene expression3→62
- Fermentation2→54
- Downregulation and upregulation1→50
- Agriculture19→58
- Antibiotic resistance15→45
- Public health4→31
- Gene6→30
- Production (economics)5→29
Where biotechnology is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in the United States
United States biotechnology patent filing is accelerating — 457,918 filings from 8,000 assignees (2016–2025), led by Genentech, UNIV California, Regeneron Pharma; annual filings 36884→44446.
- Genentech18078
- UNIV California17948
- Regeneron Pharma16082
- Amgen10495
- Monsanto Technology9742
- UNIV Pennsylvania8521
- Harvard College7460
- UNIV Texas7378
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.